The acquisition will help Thousand Oaks biotech giant Amgen broaden its product pipeline with Micromet's drug being tested as a treatment for leukemia and non-Hodgkin's lymphoma. Biotech giant Amgen, fresh off mixed earnings, said it will shell out $1.16 billion to broaden its product pipeline by buying fellow drug developer Micromet Inc.
Click here to Read
J&S Properties and Management (Panorama City, CA)
Mature Management Team or individual to manage 88 Unit Senior Citizen government subsidize Section 8 Apartment building. Experience preferred. Good...
From : JobHost -
1 day ago